NUCB2 and neoplasm: Some proteins, such as metalloproteinase inhibitor 1 (TIMP1), 78 kDa glucose‐regulated protein (GRP78), nucleobindin‐2 (NUCB2), and calbindin (CALB1), were found to be significantly changed in only the tumor‐rejecting rats (Figure 5).